Mu receptor mediated inhibition of rat urinary bladder motility: differential antagonism by kappa agonists
Sheldon, R.J.; Porreca, F.
Proceedings of the Western Pharmacology Society 30: 357-360
1987
ISSN/ISBN: 0083-8969 PMID: 2819891 Document Number: 295738
Document emailed within 1 workday
Related Documents
Horan, P.; de Costa, B.R.; Rice, K.C.; Porreca, F. 1991: Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice Journal of Pharmacology and Experimental Therapeutics 257(3): 1154-1161Hu, G.; Hu, Y.; Jin, G.Z. 1992: Antagonism of l-stepholidine on D2 receptor-mediated inhibition of synaptosomal adenylate cyclase in rat corpus striatum Zhongguo Yao Li Xue Bao 13(2): 104-110
Pechnick, R.; George, R.; Poland, R.E. 1985: Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3 Journal of Pharmacology and Experimental Therapeutics 232(1): 170-177
Sofuoglu, M.; Portoghese, P.S.; Takemori, A.E. 1991: Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes Journal of Pharmacology and Experimental Therapeutics 257(2): 676-680
Bhargava, H.N.; Ramarao, P. 1990: Antagonism of kappa opioid mediated effects in the rat by cyclo (Leu-Gly) Progress in Clinical and Biological Research 328: 493-496
von Bülow, V.; Dubben, S.; Engelhardt, G.; Hebel, S.; Plümäkers, B.; Heine, H.; Rink, L.; Haase, H. 2007: Zinc-dependent suppression of TNF-alpha production is mediated by protein kinase A-induced inhibition of Raf-1, I kappa B kinase beta, and NF-kappa B Journal of Immunology 179(6): 4180-4186
Cohen, S.M.; Zenser, T.V.; Murasaki, G.; Fukushima, S.; Mattammal, M.B.; Rapp, N.S.; Davis, B.B. 1981: Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase Cancer Research 41(9 Part 1): 3355-3359
Barbaz, B.S.; Autry, W.L.; Ambrose, F.G.; Gerber, R.; Liebman, J.M. 1985: Differential antagonism by proglumide of various CCK-mediated effects in mice Progress in Clinical and Biological Research 192: 151-158
Hall, E.D.; Wolf, D.L.; McCall, R.B. 1988: Cardiovascular depressant effects of the kappa opioid receptor agonists U50488H and spiradoline mesylate Circulatory Shock 26(4): 409-417
Lee, N.H.; Fryer, A.D.; Forray, C.; el-Fakahany, E.E. 1989: Different mechanisms of antagonism by methoctramine of two neuronal muscarinic receptor-mediated second messenger responses Journal of Pharmacology and Experimental Therapeutics 251(3): 992-999
Seiler, S.M.; Peluso, M.; Tuttle, J.G.; Pryor, K.; Klimas, C.; Matsueda, G.R.; Bernatowicz, M.S. 1996: Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists Molecular Pharmacology 49(1): 190-197
Sasaki, H.; Zhu, L.; Fukuda, S.; Maulik, N. 2000: Inhibition of NF kappa B activation by pyrrolidine dithiocarbamate prevents in vivo hypoxia/reoxygenation-mediated myocardial angiogenesis International Journal of Tissue Reactions 22(4): 93-100
Newman, S.L.; Mikus, L.K.; Tucci, M.A. 1991: Differential requirements for cellular cytoskeleton in human macrophage complement receptor- and Fc receptor-mediated phagocytosis Journal of Immunology 146(3): 967-974
Johnston, C.I.; Millar, J.A.; Casley, D.J.; McGrath, B.P.; Matthews, P.G. 1980: Hormonal responses to angiotensin blockade. Comparison between receptor antagonism and converting enzyme inhibition Circulation Research 46(6 Part 2): I128-I134
Im, C.H.; Kang, E.H.; Ki, J.Y.; Shin, D.W.; Choi, H.J.; Chang, E.J.; Lee, E.Y.; Lee, Y.J.; Lee, E.B.; Kim, H.H.; Song, Y.W. 2009: Receptor activator of nuclear factor kappa B ligand-mediated osteoclastogenesis is elevated in ankylosing spondylitis Clinical and Experimental Rheumatology 27(4): 620-625
van Vliet, B.J.; Mulder, A.H.; Schoffelmeer, A.N. 1990: Mu-opioid receptor-mediated inhibition of D-1 dopamine receptor stimulated adenylate cyclase in primary cultures of rat neostriatal neurons Progress in Clinical and Biological Research 328: 409-412
Baraban, S.C.; Lothman, E.W.; Lee, A.; Guyenet, P.G. 1995: Kappa opioid receptor-mediated suppression of voltage-activated potassium current in a catecholaminergic neuronal cell line Journal of Pharmacology and Experimental Therapeutics 273(2): 927-933
Franzoso, G.; Bours, V.; Azarenko, V.; Park, S.; Tomita-Yamaguchi, M.; Kanno, T.; Brown, K.; Siebenlist, U. 1993: The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites EMBO Journal 12(10): 3893-3901
Scott, P.A.; Chou, J.M.; Tang, H.; Frazer, A. 1994: Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists Journal of Pharmacology and Experimental Therapeutics 270(1): 198-208
Blume-Jensen, P.; Siegbahn, A.; Stabel, S.; Heldin, C.H.; Rönnstrand, L. 1993: Increased Kit/SCF receptor induced mitogenicity but abolished cell motility after inhibition of protein kinase C EMBO Journal 12(11): 4199-4209